147 related articles for article (PubMed ID: 11502805)
1. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia.
Reilly JJ; Brougham M; Montgomery C; Richardson F; Kelly A; Gibson BE
J Clin Endocrinol Metab; 2001 Aug; 86(8):3742-5. PubMed ID: 11502805
[TBL] [Abstract][Full Text] [Related]
2. Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia.
Reilly JJ; Ventham JC; Ralston JM; Donaldson M; Gibson B
Pediatr Res; 1998 Oct; 44(4):557-62. PubMed ID: 9773846
[TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity?
Jansen H; Postma A; Stolk RP; Kamps WA
Support Care Cancer; 2009 Jan; 17(1):103-6. PubMed ID: 18989711
[TBL] [Abstract][Full Text] [Related]
4. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Endocrinol Metab; 1999 Dec; 84(12):4591-6. PubMed ID: 10599724
[TBL] [Abstract][Full Text] [Related]
5. Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
Van Dongen-Melman JE; Hokken-Koelega AC; Hählen K; De Groot A; Tromp CG; Egeler RM
Pediatr Res; 1995 Jul; 38(1):86-90. PubMed ID: 7478803
[TBL] [Abstract][Full Text] [Related]
6. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
Saracco P; Bertorello N; Farinasso L; Einaudi S; Barisone E; Altare F; Corrias A; Pastore G
J Pediatr Hematol Oncol; 2005 Mar; 27(3):141-4. PubMed ID: 15750445
[TBL] [Abstract][Full Text] [Related]
7. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
8. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group.
Withycombe JS; Smith LM; Meza JL; Merkle C; Faulkner MS; Ritter L; Seibel NL; Moore K
Pediatr Blood Cancer; 2015 Mar; 62(3):434-9. PubMed ID: 25407299
[TBL] [Abstract][Full Text] [Related]
9. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
10. Resting metabolic rate and obesity in childhood acute lymphoblastic leukaemia.
Reilly JJ; Blacklock CJ; Dale E; Donaldson M; Gibson BE
Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1130-2. PubMed ID: 8968860
[TBL] [Abstract][Full Text] [Related]
11. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
12. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Barr RD
Int J Cancer Suppl; 1998; 11():81-4. PubMed ID: 9876486
[TBL] [Abstract][Full Text] [Related]
13. Premature adiposity rebound in children treated for acute lymphoblastic leukemia.
Reilly JJ; Kelly A; Ness P; Dorosty AR; Wallace WH; Gibson BE; Emmett PM;
J Clin Endocrinol Metab; 2001 Jun; 86(6):2775-8. PubMed ID: 11397886
[TBL] [Abstract][Full Text] [Related]
14. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
McNeer JL; Nachman JB
Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
[TBL] [Abstract][Full Text] [Related]
16. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
Hill G; Chauvenet AR; Lovato J; McLean TW
Pediatrics; 2005 Oct; 116(4):e525-9. PubMed ID: 16199681
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
[TBL] [Abstract][Full Text] [Related]
18. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of 11beta-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia.
Sai S; Nakagawa Y; Sakaguchi K; Okada S; Takahashi H; Hongo T; Seckl JR; Chapman KE; Ohzeki T
Leuk Res; 2009 Dec; 33(12):1696-8. PubMed ID: 19446331
[TBL] [Abstract][Full Text] [Related]
20. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
